Načítá se...
Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy
In recent years, there has been a plethora of attempts to discover biomarkers that are more reliable than α-fetoprotein for the early prediction and prognosis of hepatocellular carcinoma (HCC). Efforts have involved such fields as genomics, transcriptomics, epigenetics, microRNA, exosomes, proteomic...
Uloženo v:
| Vydáno v: | Metabolites |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7074571/ https://ncbi.nlm.nih.gov/pubmed/32012846 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo10020050 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|